The increased production of NO from the amino acid arginine in inflammatory cells like macrophages is catalyzed by the inducible nitric oxide synthase [6] and our group has previously shown that supplementation of arginine during anti-TB chemotherapy improves clinical outcome in TB patients without HIV co-infection (HIV-/TB) [7]. The gene discussed is NOS2; the disease is coinfection.